SP904: A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects with Partial-onset Seizures

Project: Research project

Project Details

StatusFinished
Effective start/end date3/5/12 → 5/1/13

Funding

  • Chiltern International, Inc. (SP904 // SP904)
  • UCB Biosciences, Inc. (SP904 // SP904)